Cyber reporting rules put device security on the board agenda

Tern plc

Mandatory cyber incident reporting in 2026 will make cybersecurity harder to treat as a back-office issue. Businesses will have to identify incidents faster, report them within strict deadlines and show regulators how they responded.

The rules increase compliance risk for companies that rely on connected devices, operational technology or complex digital supply chains. If a business cannot see what devices it has, how they are secured or whether they have been compromised, it may struggle to meet new reporting duties.

The pressure will be greatest where devices are widely deployed and difficult to manage manually. IoT and edge environments often involve many manufacturers, operators and service providers. That makes clear device identity, automated monitoring and reliable audit records more important.

The rules also create a stronger market backdrop for companies offering device security, Zero Trust access, credential management and lifecycle automation. Businesses will need systems that help them detect issues, prove what happened and respond within regulatory timeframes.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Search